Company Overview of 7TM Pharma A/S
7TM Pharma A/S discovers and develops drugs with a primary therapeutic focus on obesity/diabetes, gastrointestinal, metabolic, asthma/allergy, and vascular diseases. The company offers seven transmembrane-spanning receptors; TM38837, a small molecule CB1 receptor antagonist; TM30339, a NPY Y4 selective agonist that is used within gastrointestinal disorders, including cancer supportive care, malabsorphtion, ulcerative colitis, Crohn's disease, and short bowel syndrome; and CRTH2 antagonist, an oral drug for inflammatory/respiratory diseases. 7TM Pharma A/S was founded in 2000 and is based in Lyngby, Denmark.
Founded in 2000
45 39 25 77 77
45 39 25 77 76
Key Executives for 7TM Pharma A/S
Similar Private Companies By Industry
|Takeda Pharma A/S||Europe|
|Growth House Holding A/S||Europe|
|Oncoral Pharma ApS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact 7TM Pharma A/S, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.